We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADT
126
DELISTED
ADT Corp
ADT
| $29.5M | 0.18% |
709,357
+31,108
| +5% | +$1.17M |
|
127
Boston Scientific
BSX
$71.5B
| $29.3M | 0.18% |
1,653,027
-1,973,888
| -54% | -$31.2M |
|
128
Check Point Software Technologies
CHKP
$13.1B
| $29.3M | 0.18% |
357,886
-454
| -0.1% | -$36.7K |
|
129
Nice
NICE
$5.97B
| $29.3M | 0.18% |
480,162
-11,668
| -2% | -$642K |
|
130
Ally Financial
ALLY
$13.3B
| $29.1M | 0.18% |
1,388,026
-404,933
| -23% | -$8.53M |
|
|
PPS
131
DELISTED
Post Properties
PPS
| $28.9M | 0.18% |
508,232
-24,582
| -5% | -$1.45M |
|
132
Pilgrim's Pride
PPC
$6.54B
| $28.8M | 0.18% |
1,276,385
-172,269
| -12% | -$4.9M |
|
133
Universal Health Services
UHS
$10.5B
| $28.7M | 0.18% |
243,919
+106,327
| +77% | +$11.8M |
|
|
MFA
134
MFA Financial
MFA
$933M
| $28.4M | 0.17% |
901,829
+148,553
| +20% | +$4.7M |
|
135
Hilton Worldwide
HLT
$71.5B
| $28.2M | 0.17% |
316,801
+17,593
| +6% | +$1.45M |
|
|
AGN
136
DELISTED
Allergan plc
AGN
| $28.1M | 0.17% |
94,583
-198,438
| -68% | -$56.6M |
|
|
YHOO
137
DELISTED
Yahoo Inc
YHOO
| $28.1M | 0.17% |
633,449
+76,695
| +14% | +$3.47M |
|
|
SAFM
138
DELISTED
Sanderson Farms Inc
SAFM
| $28M | 0.17% |
350,930
-16,343
| -4% | -$1.33M |
|
139
CSX Corp
CSX
$93.1B
| $27.7M | 0.17% |
2,507,532
+1,194,345
| +91% | +$13.7M |
|
|
NUAN
140
DELISTED
Nuance Communications, Inc.
NUAN
| $27.4M | 0.17% |
2,203,690
-28,487
| -1% | -$344K |
|
|
SYA
141
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $27.2M | 0.17% |
1,157,855
| – | – |
|
142
NetApp
NTAP
$37.2B
| $27.1M | 0.17% |
764,700
+27,956
| +4% | +$1.07M |
|
143
Open Text
OTEX
$6.04B
| $26.7M | 0.16% |
1,010,802
+406,968
| +67% | +$11.6M |
|
|
CTXS
144
DELISTED
Citrix Systems Inc
CTXS
| $26M | 0.16% |
511,818
+412,892
| +417% | +$20.3M |
|
145
CRH
CRH
$66.8B
| $26M | 0.16% |
993,069
+854,476
| +617% | +$22.2M |
|
146
Keysight
KEYS
$58.3B
| $25.8M | 0.16% |
695,541
+231,136
| +50% | +$8.33M |
|
|
PDM
147
Piedmont Realty Trust
PDM
$1.19B
| $25.8M | 0.16% |
1,386,297
+282,482
| +26% | +$5.32M |
|
148
Macerich
MAC
$6.92B
| $25.7M | 0.16% |
+304,336
| New | +$26.6M |
|
|
AET
149
DELISTED
Aetna Inc
AET
| $25.3M | 0.16% |
237,955
-248,629
| -51% | -$24.4M |
|
150
Hartford Financial Services
HIG
$39.3B
| $25.3M | 0.16% |
603,890
-190,792
| -24% | -$7.82M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.